New drug pricing system leaves drugmakers in jitters

Published: 2013-06-13 06:57:00

Updated: 2013-06-13 06:57:00

Korean drug companies are said to face jitters as the National Health Insurance Corporation (NHIC) is reconsidering introducing the “reference price system (RPS),” which was already scrapped in 2002 due to vigorous oppositions from lawmakers, medical and pharmaceutical camps and civic groups.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK